Photo of Lee M. Zeldin
R United States House · District 1 · New York

Rep. Lee M. Zeldin

Compare
Total votes
958
all sessions
Attendance
88%
116 missed
Lower than 97% of chamber peers
With party
95%
of cast votes
Near the chamber average
Bipartisan score
2%
crosses aisle rarely
Near the chamber average
Sponsored
202
bills & resolutions
Lower than 87% of chamber peers
Committees
0
assignments
202 bills and resolutions

Sponsored bills

Total
202
Primary
13
Co-sponsor
189
This page
202
matching current filters
Co-sponsor HR 1690
In committee · United States House · Co-sponsor
Defending our Defenders Act

Defending Our Defenders Act This bill establishes federal criminal offenses involving the murder of federal, state, or local law enforcement officers. Violators are subject to life in prison or death. The bill sets forth aggravating factors (e.g., intent to ambush or prior history of promoting violence against a law enforcement officer) to be considered in determining whether to impose the death penalty.

In committee May 18, 2021 1 co-sponsor
Co-sponsor HR 1715
In committee · United States House · Co-sponsor
SAGA Act

Second Amendment Guarantee Act or the SAGA Act This bill prohibits a state or local government from establishing a regulation, prohibition, or registration or licensing requirement with respect to a rifle or shotgun that is more restrictive (or that imposes a greater penalty or tax) than federal law.

In committee May 18, 2021 1 co-sponsor
Co-sponsor HR 3258
In committee · United States House · Co-sponsor
TACT Act of 2021

Timely Access to Cancer Treatment Act of 2021 or the TACT Act of 2021 This bill requires insurance plans to authorize, and pharmacies contracted with the plans to dispense, anti-cancer oral medications within certain time frames. Specifically, within 24 hours after receiving a prescription, a pharmacy must inform the health care provider and plan enrollee whether it will dispense the medication. If the pharmacy will dispense the medication, it must do so within 72 hours after receiving the prescription. If the pharmacy is unable to dispense the medication, it must notify in writing the prescribing health care provider, the insurance plan, and the plan enrollee. A plan that requires prior authorization for anti-cancer oral medication must make that determination within 72 hours after receiving the request for authorization. Further, if a pharmacy provides notification that it is unable to dispense the medication, the health insurance plan must allow the enrollee to select a different pharmacy to dispense the medication, even if that pharmacy does not have a contract with the plan. In such a case, the plan may not require additional prior authorization or cost sharing. The Government Accountability Office must evaluate and report on the implementation of these requirements.

In committee May 17, 2021 1 co-sponsor
Co-sponsor HR 3259
In committee · United States House · Co-sponsor
NOPAIN Act

Non-Opioids Prevent Addiction In the Nation Act or the NOPAIN Act This bill temporarily establishes separate payments for certain non-opioid treatments under the Medicare prospective payment system for hospital outpatient department services and the payment system for ambulatory surgical center services. The bill applies to pain management treatments that are able to replace or reduce opioid consumption, as shown through clinical trials or data.

In committee May 17, 2021 1 co-sponsor
Co-sponsor HR 3183
In committee · United States House · Co-sponsor
Metastatic Breast Cancer Access to Care Act

Metastatic Breast Cancer Access to Care Act This bill expedites payment of Social Security Disability Insurance (SSDI) benefits and eligibility for Medicare coverage for those with metastatic breast cancer (i.e., breast cancer that has spread to other sites in the body). Specifically, the bill eliminates the 5-month waiting period for SSDI benefits and the subsequent 24-month waiting period for Medicare coverage for individuals with metastatic breast cancer. Under current law, individuals generally must wait five months after the onset of disability to begin receiving SSDI benefits and an additional 24 months to become eligible for Medicare.

In committee May 13, 2021 1 co-sponsor
Co-sponsor HR 3134
In committee · United States House · Co-sponsor
Combatting Racist Training in the Military Act of 2021

Combatting Racist Training in the Military Act of 2021 This bill prohibits the Armed Forces and academic institutions of the Department of Defense from promoting specified anti-American and racist theories (e.g., that any race is inherently superior or inferior to any other race). Specifically, the bill prohibits including anti-American and racist theories or materials in curricula, reading lists, seminars, workshops, trainings, or other educational or professional settings in a manner that could appear as sponsorship, approval, or endorsement; contracting with, hiring, or otherwise engaging speakers, consultants, diversity trainers, and other persons for the purpose of advocating anti-American and racist theories; compelling members of the Armed Forces to affirm or profess belief in anti-American and racist theories; and segregating members of the Armed Forces by race in any setting, including educational and training sessions.

In committee May 12, 2021 1 co-sponsor
Co-sponsor HR 3101
In committee · United States House · Co-sponsor
RIFLE Act

Repealing Illegal Freedom and Liberty Excises Act or the RIFLE Act This bill repeals the excise tax on the transfer of firearms. The bill shall not be construed as placing any regulated firearms under the jurisdiction of the U.S. Consumer Product Safety Commission.

In committee May 11, 2021 1 co-sponsor
Co-sponsor HR 3032
In committee · United States House · Co-sponsor
Jonny Wade Pediatric Cancer Research Act

Jonny Wade Pediatric Cancer Research Act This bill terminates (1) the taxpayer election to designate $3 of income tax liability for financing of presidential election campaigns, (2) the Presidential Election Campaign Fund, and (3) the Presidential Primary Matching Payment Account. The Department of the Treasury must transfer the funds remaining in the Presidential Election Campaign Fund to the 10-Year Pediatric Research Initiative Fund. The National Institutes of Health (NIH) must prioritize certain pediatric research that does not replicate existing NIH research activities.

In committee May 10, 2021 1 co-sponsor
Co-sponsor HR 3035
In committee · United States House · Co-sponsor
Preventing Foreign Attempts to Erode Healthcare Innovation Act

Preventing Foreign Attempts to Erode Healthcare Innovation Act This bill prohibits the use of federal funds to support, allow, or facilitate the negotiation or approval of any measure at the World Trade Organization to waive intellectual property rights, including the petition titled Waiver from Certain Provisions of the TRIPS Agreement for the Prevention, Containment, and Treatment of COVID-19 . (The petition was submitted by India and South Africa to suspend all intellectual property rights associated with COVID-19 innovations, such as vaccines.)

In committee May 7, 2021 1 co-sponsor
Showing 131 to 140 of 202 bills
Previous 1 … 13 14 15 … 21 Next